Emergence of SARS-COV-2 Spike Protein Escape Mutation Q493R after Treatment for COVID-19

被引：57

作者：

Focosi, Daniele ^{[1
]}

Novazzi, Federica ^{[2
]}

Genoni, Angelo ^{[3
]}

Dentali, Francesco ^{[2
,3
]}

Gasperina, Daniela Dalla ^{[2
,3
]}

Baj, Andreina ^{[2
,3
]}

Maggi, Fabrizio ^{[2
,3
]}

机构：

[1] Pisa Univ Hosp, Pisa, Italy

[2] Azienda Sociosanitaria Terr, Varese, Italy

[3] Univ Insubria, Via Dunant 5, I-21100 Varese, Italy

来源：

EMERGING INFECTIOUS DISEASES | 2021年 / 27卷 / 10期

关键词：

D O I：

10.3201/eid2710.211538

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We report in vivo selection of a severe acute respiratory syndrome coronavirus 2 spike mutation (Q493R) conferring simultaneous resistance to bamlanivimab and etesivimab. This mutation was isolated from a patient who had coronavirus disease and was treated with these drugs.

引用

页码：2728 / 2731

页数：4

共 50 条

[21] Neutralising antibody escape of SARS-CoV-2 spike protein: Risk assessment for antibody-based Covid-19 therapeutics and vaccines
Focosi, Daniele
Maggi, Fabrizio
REVIEWS IN MEDICAL VIROLOGY, 2021, 31 (06)
[22] Positive predictive value of SARS-CoV-2 spike protein antibody test after COVID-19 vaccination policies
Sookaromdee, Pathum
Wiwanitkit, Viroj
INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2023, 14 (01)
[23] IgG response to spike protein of SARS-CoV-2 in healthy individuals and potential of intravenous IgG as treatment for COVID-19
Wang, Gang
He, Zebao
Wu, Fengtian
Ge, Zhengming
Zhu, Jiansheng
Chen, Zhi
VIROLOGY JOURNAL, 2022, 19 (01)
[24] IgG response to spike protein of SARS-CoV-2 in healthy individuals and potential of intravenous IgG as treatment for COVID-19
Gang Wang
Zebao He
Fengtian Wu
Zhengming Ge
Jiansheng Zhu
Zhi Chen
Virology Journal, 19
[25] Role of cholesterol in COVID-19 disease and in the SARS-CoV-2 spike interaction
Kocar, E.
Skubic, C.
Ivanusa, P.
Brzin, J.
Rezen, T.
Turel, G.
Bogovic, P.
Strle, F.
Rozman, D.
FEBS OPEN BIO, 2021, 11 : 504 - 504
[26] Phenotypic evolution of SARS-CoV-2 spike during the COVID-19 pandemic
Furnon, Wilhelm
Cowton, Vanessa M.
De Lorenzo, Giuditta
Orton, Richard
Herder, Vanessa
Cantoni, Diego
Ilia, Georgios
Mendonca, Diogo Correa
Kerr, Karen
Allan, Jay
Upfold, Nicole
Meehan, Gavin R.
Bakshi, Siddharth
Das, Udeet Ranjan
Arias, Sergi Molina
Mcelwee, Marion
Little, Sarah
Logan, Nicola
Kwok, Kirsty
Smollett, Katherine
Willett, Brian J.
Filipe, Ana da Silva
Robertson, David L.
Grove, Joe
Patel, Arvind H.
Palmarini, Massimo
NATURE MICROBIOLOGY, 2025, 10 (01): : 77 - 93
[27] Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients
Yang Li
Dan-yun Lai
Hai-nan Zhang
He-wei Jiang
Xiaolong Tian
Ming-liang Ma
Huan Qi
Qing-feng Meng
Shu-juan Guo
Yanling Wu
Wei Wang
Xiao Yang
Da-wei Shi
Jun-biao Dai
Tianlei Ying
Jie Zhou
Sheng-ce Tao
Cellular & Molecular Immunology, 2020, 17 : 1095 - 1097
[28] SARS-CoV-2 spike protein: Site-specific breakpoints for the development of COVID-19 vaccines
Velusamy, Palaniyandi
Kiruba, Kannan
Su, Chia-Hung
Arun, Viswanathan
Anbu, Periasamy
Gopinath, Subash C. B.
Vaseeharan, Baskaralingam
JOURNAL OF KING SAUD UNIVERSITY SCIENCE, 2021, 33 (08)
[29] Inflammation in the COVID-19 airway is due to inhibition of CFTR signaling by the SARS-CoV-2 spike protein
Caohuy, Hung
Eidelman, Ofer
Chen, Tinghua
Mungunsukh, Ognoon
Yang, Qingfeng
Walton, Nathan I.
Pollard, Bette S.
Khanal, Sara
Hentschel, Shannon
Florez, Catalina
Herbert, Andrew S.
Pollard, Harvey B.
SCIENTIFIC REPORTS, 2024, 14 (01):
[30] Production of trimeric SARS-CoV-2 spike protein by CHO cells for serological COVID-19 testing
Johari, Yusuf B.
Jaffe, Stephen R. P.
Scarrott, Joseph M.
Johnson, Abayomi O.
Mozzanino, Theo
Pohle, Thilo H.
Maisuria, Sheetal
Bhayat-Cammack, Amina
Lambiase, Giulia
Brown, Adam J.
Tee, Kang Lan
Jackson, Philip J.
Wong, Tuck Seng
Dickman, Mark J.
Sargur, Ravishankar B.
James, David C.
BIOTECHNOLOGY AND BIOENGINEERING, 2021, 118 (02) : 1013 - 1021

← 1 2 3 4 5 →